{"name":"eTheRNA immunotherapies","slug":"etherna-immunotherapies","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOZ0I5ZlRoZGxrRjVYcWEwUHpKdExGSThwVXlVUjQ0Y0JpRXM4UnR2YWVKaHUzbWZUVjRTZDVBQm5XNHVXUU9zaEowOHVtT2NmamlOSGZZNm1pYkM1RklNdFd1MUJFV3BpWHF0RGlXY2tMUmYwUjQtRHZTV3RYSGI4NXNJWDYxR2xiNFlha1VFVUtVT3Bac19qeDdwdkkyV3FxN1pMeE5GMlhrdWtyYl9rbjk4c1NFOHlnYk04Yy1nc3JzVFcwSjJvRml3UUxHOVBOQmc2QXY5YnAwRjdfU1lrUXJHQVd4T2c3R0Zn?oc=5","date":"2026-02-24","type":"pipeline","source":"The Malaysian Reserve","summary":"etherna's intratumoral mRNA/LNP platform advances to clinical testing in nonmelanoma skin cancer led by Almirall - The Malaysian Reserve","headline":"etherna's intratumoral mRNA/LNP platform advances to clinical testing in nonmelanoma skin cancer led by Almirall","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOcXVOWU4tQ1p4M0RuRnBnWi1zZExUdlRvTlp6SDd2bDBsVG5EWmdXNTBYbkZFSVZveXVWVWVZTjhZcjdwdHMzR0dXeUhZUEVMZnVBQUhvWGQzUEt5T0Q5UEdoREtmQk9oa1hHaEZJbFhTNURWTmh5eWR4a1ZmTTJLekdBUk84N1lfUEp5S05naHFZanZx?oc=5","date":"2025-06-03","type":"pipeline","source":"Cleanroom Technology","summary":"Ulrich Platte is new CFO of eTheRNA immunotherapies - Cleanroom Technology","headline":"Ulrich Platte is new CFO of eTheRNA immunotherapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPNERoS1liR1ZKTy15T2w3NUdrcEVUWnlyc3A4VHZFcUFTdkp1d3hIbHgxLWx2SEY3VzFseDdxREk0YW1MSktHUlNWMXZ3a1VxOThkdFF4M1h2eC1wMkstZ2Y5NllTV2xZSzM1Qjk0UEVtckVGendZdS05RTBnTjN6VlZvRGtJeHJEcGRUT1dzT0UzdUVmUGRPVw?oc=5","date":"2025-02-07","type":"pipeline","source":"BioCentury","summary":"Science Spotlight: New protein degradation mechanism - BioCentury","headline":"Science Spotlight: New protein degradation mechanism","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQeXlGTzctOXFYczR4RWtHU01qTjhmS3BYY1JQSVJYLWRDRkNVdlFWZXQzQ011X0thaEtwdURxdV90WHRTSXpUQ2MxT3ZUSXlLZVBYUzlJSngwNExibkFWaEJISVZpUTR6dlZIcVFpZGJobXNTLW51ZzlaTTNMVzBkLU9IMTZEVHNycTNEbm1PU3hxUEZ0VnhQdkxNei11MEhLUEZObWNR?oc=5","date":"2025-01-10","type":"deal","source":"Manufacturing Chemist","summary":"etherna and Dropshot team up to optimise the RNA drug development process in $950m deal - Manufacturing Chemist","headline":"etherna and Dropshot team up to optimise the RNA drug development process in $950m deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNU1jTGVyemRpQ241OWVDdFlvWG52WFZYVVdSUDNhNU1mUWhIa01DakZZUnNQLUtPMWZoVml4d0o5d3p2MHlOck4zZ2daaUJjOU9ZU0ttOHVCS1Z1VFBEclBReVFYOThlUWQ5ei0xMXJBTFAzbnhrZDlCMFExSUdISnp0WGNlWmtiT3M0T2lzWVFsQ01MN2ZWMENpU2VTNDg1aE9IU2kxY2laV09Ka3NDRi1Sa21CLVFkcjkyeVBNem9fWnl4c0hueFRDeHJZU1UyRnBr?oc=5","date":"2025-01-09","type":"deal","source":"PR Newswire","summary":"etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics - PR Newswire","headline":"etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOMUk1bGZ6N2VXaEJYUW01UkxvaTFEMUxneTNMT2E3N1lJazQzQTJGd1FUWWFzYjVMVjBqSW5pU2NtZHBJblMtLTVReHJkZjdxR3I0MXZnN2pkSURhY3dKZlVLX0Z0V0FQVDBzWDExNzlacVFTTnlQSzhCQ25GaXdLc3p4RVA3U3BRNFpxUm5hODZNR294cWc0ZzlRRGU3cXZZREhsLQ?oc=5","date":"2025-01-09","type":"deal","source":"Fierce Biotech","summary":"Moderna co-founder Kenneth Chien's new biotech inks $950M RNA deal with Etherna - Fierce Biotech","headline":"Moderna co-founder Kenneth Chien's new biotech inks $950M RNA deal with Etherna","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZ1FTOWFsZFFyZTdSOFVycnVudC1wdU5uWjVZZEZUeDVJbklFUl9hSmc0aVhEMXk3aGtxS0lLaU5XZnZtU1F4N0JjWUdzbHA1cWZSem5oYlpYX2luazRaMWM3Y2lsRDVYX0pSdmo5T1FZODM4YmY4VDdfaFA5Ukw1Yy1oU3ZUenR6MUlsM2JhX3hYZFZIcDB1QzMtOWRqaGdSU1VRckF1VUpHUQ?oc=5","date":"2023-12-12","type":"deal","source":"Pharmaceutical Technology","summary":"Almirall taps etherna’s mRNA technology in up to $323.6m deal - Pharmaceutical Technology","headline":"Almirall taps etherna’s mRNA technology in up to $323.6m deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPMjhrS0NCQmxLWXVWUUxFSWVYeHV6T2xhUnh1NDRkTWRackNlSTNfUUNXXzJjUE1saTJXbFRTUHJrMFdTbGVmWW1TakV1ZWVnUTdWb3BFbXlaRzZoVE1MTTdrckRTQThvYVBlTnJYZkN5M0xhbkFGaVR6emFjRHV6Y2pXR0wwdUZwamg1OA?oc=5","date":"2022-12-20","type":"pipeline","source":"BioSpace","summary":"mRNA Therapeutics Market Size To Hold USD 128.14 Bn By 2030 - BioSpace","headline":"mRNA Therapeutics Market Size To Hold USD 128.14 Bn By 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPemo2eUhJOVNYQ182anNrUm1MLVpBS0dkS3BfNURvZFZMcWRXZlduZVN4azlBdnNJVjVyYWhWNDhJWnhtYTRsdlIxdUpfYmZVc2czUGJuMVRHV3ZMRUM0enBtcGh0SG53ZkotMzE5UDllZm8xbW1JOU1KcXI4X0FYdTRhWkR2VUlydlg0b3lrTQ?oc=5","date":"2022-08-01","type":"pipeline","source":"Allied Market Research","summary":"mRNA Vaccine & RNAi Therapeutics Market Size, Growth | 2031 - Allied Market Research","headline":"mRNA Vaccine & RNAi Therapeutics Market Size, Growth | 2031","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxONTdxalp2Mi1BNnNGZERZZGoxeDM1X2JjdHJBbGNrUXFoYVBibXZ6SWVtTzBJYmc2TkpzMDI0UFdHSEQ4b0ctRTdabU40am5GSElkRU43UDRVWkF2bXNjMGtiTjBVS1JVNFlJWERfNVlQUm5ocVdEak53Qkc1elBocm10RmFwV0EwS1BCLWRFUEY5c0dJNTZCWHo3RHhGMUpqX1JV?oc=5","date":"2021-06-30","type":"deal","source":"European Pharmaceutical Review","summary":"Partnership to revolutionise RNA production - European Pharmaceutical Review","headline":"Partnership to revolutionise RNA production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPYmJPMEpYdTNzOW1oTlNuamFiTkdydTk5aFdmLXVMMHc5OGFmbERfN0hMbWd1ZGNZTkxKdjNkTXNuRXNoMnA3Vm0yb2dKMVEyS3JmT3MtVG9Qb25xYXFJN0NYT3RUbm5SX2VYekxOQlJ6VWNQSjZlcC1HSU9YUmU0cXRfdExodmM?oc=5","date":"2021-05-03","type":"pipeline","source":"JD Supra","summary":"The mRNA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II) - JD Supra","headline":"The mRNA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQdXNCVDF1WjcyLU0xdldMRGNLRWNqcnJfb25LX2JQM3QyUzJxbnpZMXEtVkdFeTNWLThwdy12ZGwwOWZ2aThOVXVOeUxsWGxIazhYX2p2b2Y3WXlkSHRrTkpYSkZxY1ZsTVZtanBaclJzdzl3eFIzZHQtb0F0S0FIMjJUSVkyMVNoMUthbUFzS091dw?oc=5","date":"2020-02-05","type":"pipeline","source":"PMLiVE","summary":"New hires at Crescendo, Healx and Galecto - PMLiVE","headline":"New hires at Crescendo, Healx and Galecto","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}